Risk of Environmental Surface and Air Contamination in COVID-19 Caused by Variant Viruses (RISC-COV-Variants)

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 177699

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $398,177.26
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Allison J McGeer
  • Research Location

    Canada
  • Lead Research Institution

    Sinai Health System
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

COVID-19 is an infection caused by a virus called SARS-CoV-2. The original form of this virus first emerged in late 2019 and has caused a worldwide pandemic. This virus is transmitted from person to person, usually before or at the beginning of infection, predominantly via large respiratory droplets, although airborne smaller particles, and the contaminated environment may play a role. The best test to detect infection is with a swab of the back of the nose called a nasopharyngeal swab. Like influenza, this coronavirus changes over time. In influenza, changes in the virus mean that the virus evades immunity, so that previously infected and vaccinated people becoming re-infected. This is likely to occur with SARS-CoV-2 as well. However, the situation with coronaviruses is worse than with influenza: coronaviruses are known for their ability to change many different characteristics. Thus, although we are worried that changes may make vaccine less effective, it is also true that the virus might change how or when it is transmitted, or what the best test for detection is. Our study will take advantage of previous work with COVID-19 by our group, and a network of researchers called the Toronto Invasive Bacterial Diseases Network (www.tibdn.ca) to ask whether or not new variants of COVID have different characteristics than the original virus. For a serious of variants of SARS-CoV-2, we will study whether the air and environment around COVID-19 patients is contaminated with virus, what the best diagnostic test for COVID-19 is, and how long people test positive during their illnesses.